Dartford, United Kingdom

David Michael Skinner

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Inc.. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David Michael Skinner

Introduction

David Michael Skinner is a notable inventor based in Dartford, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his work on guanine derivatives. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

David Michael Skinner holds a patent for a guanine derivative. This invention reflects his commitment to advancing scientific knowledge and improving health outcomes through innovative solutions. The patent demonstrates his ability to merge scientific research with practical applications.

Career Highlights

Throughout his career, David has been associated with Glaxo Wellcome Inc., a leading pharmaceutical company. His role at the company has allowed him to work on groundbreaking projects that have the potential to impact the medical field significantly. His dedication to research and development has been a driving force in his career.

Collaborations

David has collaborated with esteemed colleagues such as Barry Howard Carter and Jane Muse Partin. These partnerships have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions in the pharmaceutical industry.

Conclusion

David Michael Skinner's contributions to the field of pharmaceuticals through his patent on guanine derivatives exemplify the impact of innovation in healthcare. His work continues to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…